about
MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivoΔNp63 mediates cellular survival and metastasis in canine osteosarcomaΔNp63 promotes pediatric neuroblastoma and osteosarcoma by regulating tumor angiogenesisTarget specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.Modeling the inhibition of breast cancer growth by GM-CSF.GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice.Determination of body composition in children with cerebral palsy: bioelectrical impedance analysis and anthropometry vs dual-energy x-ray absorptiometry.IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasisAn evolutionary framework for treating pediatric sarcomasA Rare Case of an Intracardiac Myoepithelial Carcinoma in an InfantGD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcomaImmunotherapeutic Challenges for Pediatric CancersTargeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other SarcomasProvocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology GroupIs Estrogen the Answer for Osteosarcoma?
P50
Q36159870-D4EF675F-D629-4F3A-99EE-C0DA2913D31BQ36934782-B7AE7E54-840A-4529-A3EA-A1DF0A53D9E3Q37565526-0A13242B-3018-4795-878A-591E4A2A9B28Q37631111-09F94DF7-3F0A-49AC-80F7-2144E66883E0Q38657451-B3C43AFC-7E4A-4BF4-8BC1-5B57B5B0EBF5Q38819030-54C25691-7163-44A9-9335-CEA71AA60F41Q47144771-AF1664FF-B69D-4BE3-BFF4-ECE983BAE1EFQ47418529-A45F4A23-BB8A-4D32-8013-CC7E0A0FD455Q51569218-0B7BA723-22CB-437B-B2BB-45D82A414C9EQ51974395-C15CEDF3-7BBA-4546-B3EF-D293EC9C232FQ58710862-9137AB78-4E46-45F0-8F56-B3EE9E15B182Q90354029-37009C73-363D-4FB3-806D-5BE2362D67B5Q90369669-D117DB95-A224-4FF8-87A6-948B9D80F7ABQ90767726-DA0EE11B-D4E7-43C3-B2D3-A67E513EE2D8Q90932874-613DA4A9-02FC-49DA-8ABC-2A3BC4397363Q92058400-76BFCAD4-EC2D-4881-AE3E-C6CCD0971EACQ92247812-F286DB88-454E-4BE1-B5EA-B9D78D41F983Q92401990-141B3531-FBD3-4500-B9BD-B5F5558CE6BA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Ryan D Roberts
@ast
Ryan D Roberts
@en
Ryan D Roberts
@es
Ryan D Roberts
@fr
Ryan D Roberts
@nl
Ryan D Roberts
@sl
type
label
Ryan D Roberts
@ast
Ryan D Roberts
@en
Ryan D Roberts
@es
Ryan D Roberts
@fr
Ryan D Roberts
@nl
Ryan D Roberts
@sl
altLabel
RD Roberts Ryan D. Roberts, Ryan David Roberts
@en
prefLabel
Ryan D Roberts
@ast
Ryan D Roberts
@en
Ryan D Roberts
@es
Ryan D Roberts
@fr
Ryan D Roberts
@nl
Ryan D Roberts
@sl
P1053
D-2573-2013
P106
P21
P214
6470157226625885410006
P31
P3829
P496
0000-0001-5028-744X
P734
P735
P7859
viaf-6470157226625885410006